FDA decisions on new oncological drugs

Lancet Oncol. 2022 May;23(5):585-586. doi: 10.1016/S1470-2045(22)00135-8.

Authors

David J Benjamin, Vinay Prasad, Mark P Lythgoe

PMID: 35489341
DOI: 10.1016/S1470-2045(22)00135-8

No abstract available

MeSH terms

Humans
Medical Oncology*
United States
United States Food and Drug Administration